These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22461662)

  • 1. Metabolic syndrome defined by modified International Diabetes Federation criteria and type 2 diabetes mellitus risk: a 9-year follow-up among the aged in Finland.
    Salminen M; Kuoppamäki M; Vahlberg T; Räihä I; Irjala K; Kivelä SL
    Diab Vasc Dis Res; 2013 Jan; 10(1):11-6. PubMed ID: 22461662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and vascular risk: a 9-year follow-up among the aged in Finland.
    Salminen M; Kuoppamäki M; Vahlberg T; Räihä I; Irjala K; Kivelä SL
    Acta Diabetol; 2011 Jun; 48(2):157-65. PubMed ID: 21234614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population.
    Noto D; Barbagallo CM; Cefalù AB; Falletta A; Sapienza M; Cavera G; Amato S; Pagano M; Maggiore M; Carroccio A; Notarbartolo A; Averna MR
    Atherosclerosis; 2008 Mar; 197(1):147-53. PubMed ID: 17466306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and incident end-stage peripheral vascular disease: a 14-year follow-up study in elderly Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Diabetes Care; 2007 Dec; 30(12):3099-104. PubMed ID: 17848614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.
    Mannucci E; Monami M; Cresci B; Pala L; Bardini G; Petracca MG; Dicembrini I; Pasqua A; Buiatti E; Rotella CM
    Diabetes Obes Metab; 2008 May; 10(5):430-5. PubMed ID: 17419722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease.
    Wassink AM; Van Der Graaf Y; Soedamah-Muthu SS; Spiering W; Visseren FLj;
    Diab Vasc Dis Res; 2008 Jun; 5(2):114-22. PubMed ID: 18537099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
    Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
    Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and risk of age-related cataract over time: an analysis of interval-censored data using a random-effects model.
    Ghaem Maralani H; Tai BC; Wong TY; Tai ES; Li J; Wang JJ; Mitchell P
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):641-6. PubMed ID: 23258144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of metabolic syndrome and prediction of diabetes using IDF versus ATPIII criteria in a Middle East population.
    Hajat C; Shather Z
    Diabetes Res Clin Pract; 2012 Dec; 98(3):481-6. PubMed ID: 23140808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormones and the risk of type 2 diabetes mellitus: A 9-year follow up among elderly men in Finland.
    Salminen M; Vahlberg T; Räihä I; Niskanen L; Kivelä SL; Irjala K
    Geriatr Gerontol Int; 2015 May; 15(5):559-64. PubMed ID: 24891075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands.
    de León AC; Coello SD; González DA; Díaz BB; Rodríguez JC; Hernández AG; Aguirre-Jaime A; Pérez Mdel C
    Diabet Med; 2012 Mar; 29(3):399-403. PubMed ID: 21883429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting glucose, obesity, and metabolic syndrome as predictors of type 2 diabetes: the Cooper Center Longitudinal Study.
    DeFina LF; Vega GL; Leonard D; Grundy SM
    J Investig Med; 2012 Dec; 60(8):1164-8. PubMed ID: 23111652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study.
    Kilpeläinen TO; Lakka TA; Laaksonen DE; Mager U; Salopuro T; Kubaszek A; Todorova B; Laukkanen O; Lindström J; Eriksson JG; Hämäläinen H; Aunola S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Uusitupa M;
    Metabolism; 2008 Mar; 57(3):428-36. PubMed ID: 18249219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing.
    Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G;
    Diabetes Metab; 2012 Apr; 38(2):135-41. PubMed ID: 22071281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.